HomeNewsBusinessDomestic hotel industry to return to pre-COVID level this fiscal, says report

Domestic hotel industry to return to pre-COVID level this fiscal, says report

According to its report, the hotel industry is expected to clock 60% of pre-COVID revenues in FY22, despite almost four months of impact because of COVID 2.0 and COVID 3.0.

April 13, 2022 / 21:24 IST
Story continues below Advertisement
Representative image
Representative image

The country's hotel industry is expected to return to the pre-COVID level in the current fiscal itself on the back of a significant improvement in demand, according to a report.

Rating agency Icra's Assistant Vice President and Sector Head Vinutaa S on Wednesday said that demand in the near term is expected to stem largely from domestic leisure travel, although there will be gradual recovery in business travel and free trade agreements (FTAs). According to its report, the hotel industry is expected to clock 60 per cent of pre-COVID revenues in FY22, despite almost four months of impact because of COVID 2.0 and COVID 3.0.

Story continues below Advertisement

ALSO READ: Hotels, multiplexes limp out of virus blues, shares begin to perk up

"Further, the industry is also likely to report operating profits in FY22 aided by improved operating leverage and sustenance of some of the cost-optimisation measures undertaken in FY21," Vinutaa said. Inspite of the potential impact on demand with further COVID waves, if any, she said that Icra expects the industry to return to pre-COVID levels in FY23, as against FY24 earlier.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show